| Welcome, Guest |
You have to register before you can post on our site.
|
| Latest Threads |
Odds and Ends ... With So...
Forum: The Lounge
Last Post: IceWizard
11-13-2026, 01:20 AM
» Replies: 11
» Views: 3,075
|
Here are a couple I found
Forum: IOPList Suggested IOP's
Last Post: gujjernoran
11-12-2026, 08:26 PM
» Replies: 1
» Views: 795
|
www.MacroMass.COM.PH
Forum: IOPList (Approved & Recommended)
Last Post: Macro Mass
11-11-2026, 04:56 PM
» Replies: 3,854
» Views: 7,142,119
|
The Juke Box is OPEN
Forum: The Lounge
Last Post: Mr. HIND
11-09-2026, 08:03 AM
» Replies: 2,939
» Views: 1,664,197
|
MOVIES
Forum: The Lounge
Last Post: IceWizard
11-09-2026, 05:10 AM
» Replies: 147
» Views: 49,486
|
www.MacroMass.COM.PH
Forum: IOP Discounts, Offers & More
Last Post: Macro Mass
11-08-2026, 09:07 PM
» Replies: 143
» Views: 81,114
|
Humorous Smilies
Forum: The Lounge
Last Post: IceWizard
11-02-2026, 01:22 AM
» Replies: 4,936
» Views: 4,267,962
|
Deaths So Far (and it's j...
Forum: World News
Last Post: IceWizard
10-31-2026, 07:15 PM
» Replies: 51
» Views: 14,545
|
'Biscuit' the dog is late...
Forum: World News
Last Post: IceWizard
10-31-2026, 06:16 PM
» Replies: 0
» Views: 157
|
GAME - Change one word ga...
Forum: The Lounge
Last Post: IceWizard
10-15-2026, 05:21 AM
» Replies: 2,142
» Views: 1,020,381
|
|
|
| Just a quick introduction |
|
Posted by: TheDoors - 08-29-2017, 06:01 PM - Forum: Welcome
- Replies (24)
|
 |
Hi,
After finding this site and reading the rules, thought I'd start by making an introduction.
Just your average guy who's seeking help finding alternatives to the DN, helping manage my anxiety since my Health Care System couldn't care less. A sad state of affairs, but needs must.
I have no experience ordering from IOP's so any guidance will be greatly received.
I hope you are all well.
Regards, TheDoors
|
|
|
| All clear for the decisive trial of ecstasy in PTSD patients |
|
Posted by: Linville - 08-28-2017, 03:24 PM - Forum: World News
- Replies (11)
|
 |
Can you believe this?
==========
All clear for the decisive trial of ecstasy in PTSD patients
By [color=var(--body-font-color)]Kai KupferschmidtAug. 26, 2017 , 6:30 PM[/color]
[color=rgba(0, 0, 0, 0.65098)]![[Image: ecstacy-03_16x9.jpg?itok=hjuXh0hJ]](http://www.sciencemag.org/sites/default/files/styles/inline__450w__no_aspect/public/ecstacy-03_16x9.jpg?itok=hjuXh0hJ)
[color=rgba(0, 0, 0, 0.65098)]MDMA is better known as the party drug ecstasy.[/color]
[color=rgba(0, 0, 0, 0.65098)]DEA [/color]
[/color]
One of the main targets in the war on drugs could well become a drug to treat the scars of war.
The U.S. Food and Drug Administration (FDA) has designated 3,4-methylenedioxymethamphetamine (MDMA), better known as the illegal drug ecstasy, a "breakthrough therapy" for posttraumatic stress disorder (PTSD), a status that may lead to faster approval.
The agency has also approved the design for two phase III studies of MDMA for PTSD that would be funded by the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit in Santa Cruz, California. MAPS announced the "breakthrough therapy" designation, made by FDA on 16 August, on its website today; if the group can find the money for the trials, which together could cost an estimated $25 million, they may start next spring and finish by 2021.
That an illegal dancefloor drug could become a promising pharmaceutical is another indication that the efforts of a dedicated group of researchers interested in the medicinal properties of mind-altering drugs is paying dividends. Stringent drug laws have stymied research on these compounds for decades. "This is not a big scientific step," says David Nutt, a neuropsychopharmacologist at Imperial College London. "It’s been obvious for 40 years that these drugs are medicines. But it’s a huge step in acceptance."
Since 2012, FDA has designated close to 200 drugs as breakthrough therapies, a status that indicates there’s preliminary evidence that an intervention offers a substantial improvement over other options for a serious health condition. The agency aims to help develop and review these treatments faster than other candidate drugs.
In people with PTSD, a small sensory trigger such as a sound or a smell can bring a traumatic memory rushing back. “The disabling element of PTSD is the fact that when the memory starts, the emotions completely override you and overwhelm the brain,” Nutt says. Studies suggest that MDMA can dampen the emotional response to the memory, allowing people to relive their trauma and work through it, he says. The MDMA-treatment consists of several sessions of psychotherapy, some conducted while the patient is under the influence of the drug.
MAPS Executive Director Rick Doblin set up the group in 1986, one year after the U.S. Drug Enforcement Administration made MDMA an illegal drug, because he was convinced of its therapeutic potential. Since then, MAPS has poured millions into trials of MDMA, for PTSD and other conditions, and has taken the lead in conducting them. The FDA designation is "kind of a public acknowledgement of the promise of this research,” Doblin says.
A small U.S. study that first suggested MDMA could help treat PTSD was published in 2011. Since then, researchers in Canada, Israel, and the United States have jointly carried out larger phase II trials funded by MAPS; their results, which remain unpublished but have been reviewed by the FDA, were very good, says Doblin. Overall, 107 participants who had suffered from PTSD for an average of 17.8 years were treated in the phase II trials, Doblin says. Of the 90 patients who were available to be studied 12 months later, 61 no longer had PTSD.
In late July, says Doblin, MAPS and FDA agreed on how the coming phase III trials—usually the last hurdle before seeking a drug's approval from regulators—should be conducted. A key issue that has dogged randomized controlled trials of MDMA and other mind-altering drugs is how to minimize bias. In many trial designs, some patients receive a drug while others are in a control group that receives a placebo. The participants aren’t told which they received, but patients who get MDMA can often tell, which might have an effect all by itself.
In past studies, patients in the control arm received a low dose of MDMA—a so-called "active placebo"—that made it harder for them to tell in which group they were. But that had a negative effect on the outcome of their psychotherapy, says Doblin, making MDMA look better by comparison. A low dose "activates people, but it does not provide the fear reduction that the full doses would and so they are more uncomfortable, more unhappy,” Doblin says.
That's why FDA decided it would be better to test MDMA-assisted psychotherapy against psychotherapy with an inactive placebo. But the agency and MAPS agreed on additional measures to ensure that the doctors who evaluate the patients don’t know if they received the real drug.
The biggest hurdle now is raising the money for the two phase III trials, which together will include between 200 and 300 participants. So far MAPS has raised only $12.75 million, about half of its goal, and an effort to crowdfund the rest has been disappointing. "I think the money will come from major donors,” Doblin says. "We are going to people in the tech world and family foundations, but we're also trying with the Veterans Administration.”
The first phase III trial will start no matter what, he says. "It’s always been the philosophy of MAPS that if we can do the work, the money will follow.”
MAPS has not conducted trials in Europe yet but is planning to start discussion with the European Medicines Agency, the European Union's regulatory body, soon. Nutt says that after overcoming major regulatory hurdles, he is about to start a trial using MDMA to treat alcohol addiction.
doi:10.1126/science.aap7739
|
|
|
Until We Update Surveillance Laws, Govt Can Snoop on You... |
|
Posted by: Dancing Wolf - 08-26-2017, 03:06 PM - Forum: Political Discussion
- Replies (7)
|
 |
Until We Update Surveillance Laws, Government Can Snoop On Your Phone And Email At Will
By Dan Hill 8/24/17
While the ECPA Modernization Act is by no means a cure-all for the erosion of privacy rights in America, it certainly would move the nation in the right direction.
![[Image: 124659356_bbe1e5b661_o-998x666.jpg]](http://thefederalist.com/wp-content/uploads/2017/08/124659356_bbe1e5b661_o-998x666.jpg)
For decades, Americans have forfeited their privacy rights for a false sense of safety. Broad, sweeping surveillance laws––such as, but certainly not limited to Section 702 of the FISA Amendments Act––have given the federal government carte blanche in the realm of surveillance. Thankfully, a recently introduced bipartisan Senate bill would restore some vital protections to Americans’ privacy.
The ECPA Modernization Act, introduced by Sens. Mike Lee (R-UT) and Patrick Leahy (D-VT), would update the Electronic Communications Privacy Act of 1986 (ECPA) to make it more relevant to the technologically advanced world in which we live. The original bill was conceived in a time when email and cell phone use were rare, with the goal of protecting oral, wire, and electronic communications from government surveillance. The bill was an update to the 1968 Federal Wiretap Act, which, much like the ECPA now, had become useless with time.
ECPA’s privacy protections remain stuck in that era, when companies would only archive emails for 180 days. After that time frame had lapsed, a user’s emails would disappear, thus ending the government’s ability to snoop archives. Servers have since made email archives essentially eternal, giving the government a goldmine of information to spy on.
Legislators at that time could not have foreseen surveillance tools, such as facial recognition technology, Internet dragnets, and cell site simulators, all of which have been deployed to trample privacy rights. While lawmakers may have had good intentions in 1986, their bill is useless in the modern era.
It’s 10 O’Clock. Yes, Government Knows Where You Are
The ECPA does nothing to address spy agency and police use of geolocation data to track the exact whereabouts of a person. That type of tracking has been used in startling ways recently. Earlier this year, Immigration and Customs Enforcement (ICE) used a Stingray cell site simulator to track down an illegal immigrant in Detroit. That was the first time ICE deployed this tool, which was originally designed for military and terror investigations. Police in New York have used the tool thousands of times, and the Electronic Frontier Foundation (EFF) reports it is repeatedly abused in non-terror investigations across the country.
Dan King is an advocate for Young Voices and a journalist residing in Arlington, Virginia. He writes about free speech, mass surveillance, civil liberties and LGBT issues.
Article at http:// thefederalist.com /2017/08/24/update-surveillance-laws-government-can-snoop-phone-email-will/
_____________________
Now I read they want to implant devices inside us so they can track us everywhere
They have also developed 'delivery methods' so people could ingest this without knowing they were doing it...
It's nice to see a democrat and republican working Together on legislation that might actually benefit Americans and freedom.
.
|
|
|
| To All in Harvey's Path |
|
Posted by: Orange rabbit - 08-26-2017, 03:51 AM - Forum: World News
- Replies (25)
|
 |
For all of you in Harvey's path tonight and the next 4-5 days, please stay safe. Don't do anything stupid. Take cover, listen to the news, and be with your family.
We are praying for all of you.
OR
|
|
|
| Hurricane |
|
Posted by: Oxford - 08-26-2017, 03:45 AM - Forum: Anxiety Depression & Stress
- No Replies
|
 |
Just escaped Houston as I have said before I travel in my work so now I'm in El Paso Texas I know 20 years ago I crossed border and got 90 day supply of my anxiety meds ect
Just wondering if laws have changed or if anyone has crossed border to Mexico lately
And has any information on this
As always thanks for any help
|
|
|
|